The Union for International Cancer Control (UICC) is taking a leading role at the 78th World Health Assembly (WHA78), held from 19 to 27 May 2025 in Geneva, with a series of high-profile engagements aimed at strengthening global cancer control. Through partnerships, technical forums, and policy discussions, UICC is highlighting the urgent need for integrated, collaborative approaches to cancer care.
A major highlight of UICC’s WHA78 presence is the co-hosting of an official side event with the Government of Malaysia on Wednesday, 21 May. Titled “The integrated lung health resolution: creating a unified approach to prevention, early identification and care”, the event aims to advance implementation of the integrated lung health resolution, with particular emphasis on its implications for lung cancer.
UICC CEO Cary Adams will join a panel of experts to discuss the potential of multisectoral collaboration in improving outcomes for lung diseases. “Unified policy approaches are essential to enabling earlier diagnosis, more coordinated prevention, and ultimately, better patient care,” said Adams. The event supports UICC’s leadership in the Lung Cancer Collaboration initiative.
On the morning of 21 May, UICC will co-organise another key side event: “Mobilising action on AMR for better cancer care”. This collaborative session—held with the Health Diplomacy Alliance, CARB-X, the Norwegian and Swedish Cancer Societies, GARDP, and the IDA Foundation—addresses the escalating threat of antimicrobial resistance (AMR) to effective cancer treatment.
With cancer patients particularly vulnerable to infections due to weakened immune systems, the discussion will focus on aligning AMR strategies with cancer care to ensure access to effective antimicrobials. The event also seeks to build awareness among noncommunicable disease (NCD) stakeholders about the importance of joint advocacy and coordinated policy-making.
On 22 May, UICC will host an event in collaboration with partners from the Access to Oncology Medicines (ATOM) Coalition. The gathering will reflect on three years of progress in enhancing access to essential cancer medicines, especially in low- and middle-income countries.
UICC’s WHA78 advocacy also includes participation in WHO-led discussions on ensuring balanced access to controlled medicines. More than 75% of the global population still lacks adequate access to pain relief, a situation that UICC argues must change for the sake of human dignity and quality cancer care. By supporting policies that improve palliative care access, UICC continues its push to put patients at the center of the global health agenda.
Throughout WHA78, UICC leaders—including CEO Cary Adams and members of the Board—are actively engaging with Member States, technical experts, and civil society actors. These strategic interactions aim to ensure that cancer control remains a central issue in global health decision-making.
By spotlighting lung health, AMR, medicine access, and palliative care, UICC is not only advocating for better cancer outcomes but also reinforcing the need for integrated health systems that serve the most vulnerable populations.
